Alpha-interferon induced sarcoidosis mimicking metastatic melanoma

被引:14
|
作者
North, Jeffrey [1 ,2 ]
Mully, Thaddeus
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA
[2] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA
关键词
cancer; cytokines; immunology; melanoma; RHEUMATOID-ARTHRITIS; ETANERCEPT THERAPY; MALIGNANT-MELANOMA; PULMONARY SARCOIDOSIS; CUTANEOUS SARCOIDOSIS; PATIENT; INFLIXIMAB; INTERLEUKIN-2; GRANULOMA; CANCER;
D O I
10.1111/j.1600-0560.2011.01702.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Despite its modest potential benefit, alpha-interferon is one of the most frequently employed therapies for melanoma. With the increasing incidence of melanoma, a parallel increase in interferon use and the associated adverse reactions that accompany interferon therapy should be expected. We present a case of an interferon-induced sarcoidosis-like reaction in a melanoma patient that was initially misinterpreted clinically and radiographically as metastatic melanoma. The etiology of sarcoidosis remains a mystery, but appears to involve Th-1 cytokines such as interferon and interleukin-2. Observance of a sarcoidosis-like reaction induced by interferon therapy lends additional support to the importance of this cytokine in the pathogenesis of sarcoidosis. It is important for pathologists to be aware of this entity when interpreting biopsies from melanoma patients treated with interferon.
引用
收藏
页码:585 / 589
页数:5
相关论文
共 50 条
  • [41] TREATMENT OF HEMANGIOENDOTHELIOMAS WITH ALPHA-INTERFERON
    ORCHARD, PJ
    SMITH, CM
    WOODS, WG
    DAY, DL
    DEHNER, LP
    SHAPIRO, R
    LANCET, 1989, 2 (8662): : 565 - 567
  • [42] ALPHA-INTERFERON - A LOOK TO THE FUTURE
    BONNEM, EM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 : S65 - S75
  • [43] ALPHA-INTERFERON AND LYMPHOID HEMOPATHIES
    FLANDRIN, G
    ANNALES DE MEDECINE INTERNE, 1988, 139 (08): : 530 - 533
  • [44] ALPHA-INTERFERON IN THROMBOCYTOPENIC PURPURA
    TAILLAN, B
    FUZIBET, JG
    PESCE, A
    VINTI, H
    SANDERSON, F
    DUJARDIN, P
    CASSUTO, JP
    LANCET, 1988, 2 (8603): : 170 - 170
  • [45] PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON IN MALIGNANT-MELANOMA
    NEEFE, JR
    LEGHA, SS
    MARKOWITZ, A
    SALMON, S
    MEYSKENS, F
    GROOPMAN, J
    CAMPION, M
    EVANS, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 472 - 476
  • [46] Psoriatic arthritis and alpha-interferon
    Olivieri, I
    Padula, A
    Ciancio, G
    La Civita, L
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (03) : 175 - 175
  • [47] TREATMENT OF HBV WITH ALPHA-INTERFERON
    BROOK, MG
    CHAN, G
    YAP, I
    KARAYIANNIS, P
    LEVER, AML
    JACYNA, M
    MAIN, J
    THOMAS, HC
    GUT, 1989, 30 (05) : A707 - A707
  • [48] A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma
    Guillot, B
    Blazquez, L
    Bessis, D
    Dereure, O
    Guilhou, JJ
    DERMATOLOGY, 2004, 208 (01) : 49 - 54
  • [49] Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis
    Wong, V
    Fu, AXL
    George, J
    Cheung, NW
    CLINICAL ENDOCRINOLOGY, 2002, 56 (06) : 793 - 798
  • [50] CONTRIBUTION OF ALPHA-INTERFERON (ALPHA-IFN) TO HIV-INDUCED IMMUNOSUPPRESSION
    LACHGAR, A
    BIZZINI, B
    CELLULAR AND MOLECULAR BIOLOGY, 1995, 41 (03) : 431 - 437